GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE

被引：0
|
作者：
CARMELIET, P
SCHOONJANS, L
STASSEN, JM
KIECKENS, L
VANNUFFELEN, A
DEMOL, M
COLLEN, D
MULLIGAN, R
机构：
[1] WHITEHEAD INST,CAMBRIDGE,MA
[2] CATHOLIC UNIV LEUVEN,CTR THROMBOSIS & VASC RES,B-3000 LOUVAIN,BELGIUM
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [1] ON THE REVERSIBLE INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    VANHOEF, B
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4041 - 4044
  • [2] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    STASSEN, JM
    BRONSON, R
    COLLEN, D
    MULLIGAN, R
    FIBRINOLYSIS, 1993, 7 : 27 - 28
  • [3] BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE
    CARMELIET, P
    BOUCHE, A
    DECLERCQ, C
    JANSSEN, S
    POLLEFEYT, S
    WYNS, S
    MULLIGAN, RC
    COLLEN, D
    ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 367 - 382
  • [4] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 I IN BREAST-CANCER CELLS
    WAJIMA, T
    DEGEN, D
    ORIZ, V
    VONHOFFOLIN, DD
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1284 - 1284
  • [5] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA
    JORGENSEN, M
    PHILIPS, M
    THORSEN, S
    SELMER, J
    ZEUTHEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 872 - 878
  • [6] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN RAYNAUD PHENOMENON
    SILVERI, F
    SERRETTI, R
    CORE, P
    BRECCIAROLI, D
    THROMBOSIS RESEARCH, 1993, 70 : S93 - S93
  • [7] DEPRESSION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ENHANCEMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AS AN EXPRESSION OF LOCAL INFLAMMATION
    BROMMER, EJP
    DOOIJEWAARD, G
    DIJKMANS, BAC
    BREEDVELD, FC
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (02) : 180 - 184
  • [8] VITRONECTIN GOVERNS THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    KEIJER, J
    EHRLICH, HJ
    LINDERS, M
    PREISSNER, KT
    PANNEKOEK, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (16) : 10700 - 10707
  • [9] LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1,2 AND PLASMINOGEN IN COLON-CANCER
    NAITOH, H
    EGUCHI, Y
    UEYAMA, H
    KODAMA, M
    HATTORI, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 48 - 56
  • [10] KINETICS OF INHIBITION OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TYPE-2
    THORSEN, S
    PHILIPS, M
    SELMER, J
    LECANDER, I
    ASTEDT, B
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (01): : 33 - 39
12345